Steven R. Alberts, MD, MPH | Authors

""UNIVERSITY OF FLORIDA JACKSONVILLE PHYSICIANS, INC.""

UFJP INTERNAL MEDICINE

655 W 8TH ST

Articles

Colon, Rectal, and Anal Cancers

June 01, 2016

This management guide covers the risk factors, symptoms, diagnosis, staging, and treatment of colorectal and anal cancers.

Cancer Management Chapter 13: Colon, rectal, and anal cancers

March 10, 2010

Despite the existence of excellent screening and preventive strategies, colorectal carcinoma (CRC) remains a major public health problem in Western countries. The American Cancer Society (ACS) estimated that in 2009, 146,970 people will be diagnosed with CRC, and 49,920 will die of the disease. CRC is the third most common type of cancer in both sexes (after prostate and lung cancers in men and lung and breast cancers in women) and the second most common cause of cancer death in the United States.

Issues Relating to Cytotoxic and Biologic Agents in Liver-Limited Disease

August 16, 2009

About the ActivityThis activity is based on a brief article developed as part of the E-Update Series and posted on the Web. It was developed from an identified educational need for information about practical management issues in the practice of medical, surgical, and radiation oncology. This activity has been developed and approved under the direction of CME LLC.

Pancreatic Cancer in the Older Patient

July 01, 2001

Pancreatic cancer is a disease seen predominantly in elderly patients. Compared to younger patients, older patients are more likely to present with early-stage disease and, therefore, may be candidates for aggressive local

Intrahepatic Therapy for Resected Hepatic Metastases From Colorectal Carcinoma

December 01, 2000

A significant number of patients with colorectal cancer will present with hepatic metastases as their only site of metastatic disease. Surgical resection in patients with a limited number of metastases will lead to long-term

Therapy for Early-Stage Colorectal Cancer

March 01, 1999

The article by Drs. Peeters and Haller provides the details of 20 years of investigation into the adjuvant therapy of colorectal cancer. The authors describe pivotal trials through which an international cast of investigators have identified adjuvant